Spread of triple-negative breast cancer could be halted with
Published in the journal Nature Communications, the study reveals that drugs that block an enzyme pathway called CDK 4/6 - known as CDK 4/6 inhibitors - prevented the spread of triple-negative breast cancer in a number of models.

After skin cancer, breast cancer is the most common cancer among women in the United States. In 2017, approximately 252,710 new cases of invasive breast cancer will be diagnosed in the U.S., and around 40,610 women will die from the disease.

Estrogen receptor-positive (ER-positive) breast cancer is the most common form of breast cancer, whereby the breast cancer cells contain receptors for the hormone estrogen. When these receptors receive signals from the hormone, this can promote cancer cell growth....

http://www.medicalnewstoday.com/articles/315110.php
Like
Comment
Share